These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 17727564

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of the European LeukaemiaNet criteria for clinicohaematological response and resistance/intolerance to hydroxycarbamide in essential thrombocythaemia.
    Hernández-Boluda JC, Alvarez-Larrán A, Gómez M, Angona A, Amat P, Bellosillo B, Martínez-Avilés L, Navarro B, Teruel A, Martínez-Ruiz F, Besses C.
    Br J Haematol; 2011 Jan; 152(1):81-8. PubMed ID: 21083657
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Leg ulcers and hydroxyurea: report of three cases with essential thrombocythemia.
    Demirçay Z, Cömert A, Adigüzel C.
    Int J Dermatol; 2002 Dec; 41(12):872-4. PubMed ID: 12492973
    [Abstract] [Full Text] [Related]

  • 11. Hydroxyurea-induced hemolytic anemia in a patient with essential thrombocythemia.
    Jabr FI, Shamseddine A, Taher A.
    Am J Hematol; 2004 Dec; 77(4):374-6. PubMed ID: 15558807
    [Abstract] [Full Text] [Related]

  • 12. Evolving management of essential thrombocythaemia.
    Barbui T.
    Eur J Haematol Suppl; 2007 Oct; (68):22-3. PubMed ID: 17727561
    [No Abstract] [Full Text] [Related]

  • 13. Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug.
    Passamonti F, Cazzola M.
    Haematologica; 2004 Nov; 89(11):1284. PubMed ID: 15531447
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nail changes after chemotherapy.
    Las Heras G, Juncà Piera J.
    Haematologica; 1998 Aug; 83(8):748. PubMed ID: 9793260
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor?
    Vélez A, García-Aranda JM, Moreno JC.
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):243-4. PubMed ID: 10461646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.